The peripheral interventions market size has grown strongly in recent years. It will grow from $10 billion in 2025 to $10.91 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, aging population with vascular disorders, advancements in catheter-based technologies, increased clinical awareness of limb ischemia, improved reimbursement for endovascular procedures.
The peripheral interventions market size is expected to see strong growth in the next few years. It will grow to $15.28 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing preference for minimally invasive treatments, technological innovation in stents and guide wires, expansion of ambulatory surgical centers, increasing healthcare expenditure in emerging markets, rising demand for faster recovery procedures. Major trends in the forecast period include shift toward minimally invasive peripheral procedures, growing adoption of drug-eluting and covered stents, increasing use of image-guided endovascular interventions, rising demand for atherectomy and thrombectomy devices, expansion of peripheral interventions in outpatient settings.
The growing demand for minimally invasive procedures is expected to drive the expansion of the peripheral interventions market. Minimally invasive procedures involve performing surgeries or treatments through small incisions or natural body openings, which results in less trauma, reduced pain, and quicker recovery compared to traditional open surgeries. This rise in minimally invasive procedures is fueled by advancements in medical imaging and surgical technologies that improve precision and safety during operations. Peripheral interventions support minimally invasive approaches by enabling targeted treatment of vascular conditions through small incisions, decreasing the necessity for open surgery. For example, in June 2024, the American Society of Plastic Surgeons, a US-based professional organization, reported that approximately 25.4 million minimally invasive procedures were performed in 2023, marking a 7% increase from 2022. Hence, the increasing demand for minimally invasive procedures is driving growth in the peripheral interventions market.
Key players in the peripheral interventions market are concentrating on developing innovative solutions such as peripheral intravascular lithotripsy (IVL) catheters to improve the safety and effectiveness of treating calcified peripheral artery disease. These catheters use sonic pressure waves to fracture calcified plaque in peripheral arteries, facilitating safer and easier angioplasty or stent placement. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, introduced the Shockwave Javelin Peripheral IVL Catheter, a new forward IVL platform designed for patients with peripheral artery disease (PAD) who have difficult-to-cross, heavily calcified lesions. This catheter has a 150 cm working length and a single distal emitter delivering up to 120 shockwave pulses, generating a spherical energy field that modifies calcium and allows the device to navigate extremely narrowed or blocked vessels where other devices may fail. Clinical trials showed that Javelin’s safety and efficacy are comparable to existing balloon-based IVL catheters, providing a transformative solution for treating complex calcified peripheral lesions and improving procedural outcomes for PAD patients.
In July 2025, Teleflex Incorporated, a US-based medical technology company, acquired the vascular intervention business of Biotronik SE & Co. KG for $892 million. This acquisition enables Teleflex to broaden its global reach in the peripheral intervention market, enhance its interventional cardiology product portfolio, and utilize Biotronik’s Vascular Intervention business to strengthen product offerings and research and development capabilities. Biotronik SE & Co. KG is a Germany-based firm specializing in products and solutions for coronary and peripheral vascular interventions.
Major companies operating in the peripheral interventions market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., Cordis Corporation, MicroPort Scientific Corporation, Penumbra Inc., W. L. Gore & Associates Inc., Reflow Medical Inc., ArtVentive Medical Group Inc., AngioDynamics Inc., Cook Medical Inc., BD Bard Peripheral Vascular Inc., Endologix Inc., Cardiovascular Systems Inc., Surmodics Inc.
North America was the largest region in the peripheral interventions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral interventions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral interventions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced cost pressures in the peripheral interventions market by increasing prices of imported medical devices, raw materials, and precision components used in catheters, stents, and guide wires. These trade barriers have disrupted global supply chains and raised procurement costs for hospitals and ambulatory surgical centers, with stronger impact across product types such as drug-eluting stents and atherectomy devices, particularly in regions dependent on imports like asia-pacific and latin america. However, tariffs have also encouraged local manufacturing, regional sourcing, and strategic partnerships, supporting domestic production capabilities and reducing long-term dependency on cross-border supply chains.
The peripheral interventions market research report is one of a series of new reports that provides peripheral interventions market statistics, including peripheral interventions industry global market size, regional shares, competitors with a peripheral interventions market share, detailed peripheral interventions market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral interventions industry. This peripheral interventions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peripheral interventions are minimally invasive procedures designed to diagnose and treat conditions affecting the peripheral blood vessels outside the heart and brain, such as those in the legs, arms, or abdomen. These interventions commonly aim to restore circulation in the arteries of the limbs or abdomen using image-guided techniques.
The main products used in peripheral interventions include catheters, sheaths, stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, inferior vena cava (IVC) filters, and others. Catheters are thin, flexible tubes employed in medical procedures to deliver or remove fluids, administer medications, measure pressures, or guide other devices into blood vessels, organs, or body cavities for diagnostic or therapeutic purposes. The technologies involved include drug-eluting stents, balloon-expandable stents, self-expanding stents, rotational atherectomy, and directional atherectomy. These products are primarily applied in conditions such as peripheral artery disease, venous thromboembolism, and others, serving a diverse range of end users, including hospitals, ambulatory surgical centers, clinics, and research institutes.
The peripheral interventions market consists of revenues earned by entities providing services such as angioplasty and stenting procedures, atherectomy services, thrombectomy procedures, vascular imaging and diagnostics, and post-procedural patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The peripheral interventions market size is expected to see strong growth in the next few years. It will grow to $15.28 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing preference for minimally invasive treatments, technological innovation in stents and guide wires, expansion of ambulatory surgical centers, increasing healthcare expenditure in emerging markets, rising demand for faster recovery procedures. Major trends in the forecast period include shift toward minimally invasive peripheral procedures, growing adoption of drug-eluting and covered stents, increasing use of image-guided endovascular interventions, rising demand for atherectomy and thrombectomy devices, expansion of peripheral interventions in outpatient settings.
The growing demand for minimally invasive procedures is expected to drive the expansion of the peripheral interventions market. Minimally invasive procedures involve performing surgeries or treatments through small incisions or natural body openings, which results in less trauma, reduced pain, and quicker recovery compared to traditional open surgeries. This rise in minimally invasive procedures is fueled by advancements in medical imaging and surgical technologies that improve precision and safety during operations. Peripheral interventions support minimally invasive approaches by enabling targeted treatment of vascular conditions through small incisions, decreasing the necessity for open surgery. For example, in June 2024, the American Society of Plastic Surgeons, a US-based professional organization, reported that approximately 25.4 million minimally invasive procedures were performed in 2023, marking a 7% increase from 2022. Hence, the increasing demand for minimally invasive procedures is driving growth in the peripheral interventions market.
Key players in the peripheral interventions market are concentrating on developing innovative solutions such as peripheral intravascular lithotripsy (IVL) catheters to improve the safety and effectiveness of treating calcified peripheral artery disease. These catheters use sonic pressure waves to fracture calcified plaque in peripheral arteries, facilitating safer and easier angioplasty or stent placement. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, introduced the Shockwave Javelin Peripheral IVL Catheter, a new forward IVL platform designed for patients with peripheral artery disease (PAD) who have difficult-to-cross, heavily calcified lesions. This catheter has a 150 cm working length and a single distal emitter delivering up to 120 shockwave pulses, generating a spherical energy field that modifies calcium and allows the device to navigate extremely narrowed or blocked vessels where other devices may fail. Clinical trials showed that Javelin’s safety and efficacy are comparable to existing balloon-based IVL catheters, providing a transformative solution for treating complex calcified peripheral lesions and improving procedural outcomes for PAD patients.
In July 2025, Teleflex Incorporated, a US-based medical technology company, acquired the vascular intervention business of Biotronik SE & Co. KG for $892 million. This acquisition enables Teleflex to broaden its global reach in the peripheral intervention market, enhance its interventional cardiology product portfolio, and utilize Biotronik’s Vascular Intervention business to strengthen product offerings and research and development capabilities. Biotronik SE & Co. KG is a Germany-based firm specializing in products and solutions for coronary and peripheral vascular interventions.
Major companies operating in the peripheral interventions market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., Cordis Corporation, MicroPort Scientific Corporation, Penumbra Inc., W. L. Gore & Associates Inc., Reflow Medical Inc., ArtVentive Medical Group Inc., AngioDynamics Inc., Cook Medical Inc., BD Bard Peripheral Vascular Inc., Endologix Inc., Cardiovascular Systems Inc., Surmodics Inc.
North America was the largest region in the peripheral interventions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral interventions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripheral interventions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced cost pressures in the peripheral interventions market by increasing prices of imported medical devices, raw materials, and precision components used in catheters, stents, and guide wires. These trade barriers have disrupted global supply chains and raised procurement costs for hospitals and ambulatory surgical centers, with stronger impact across product types such as drug-eluting stents and atherectomy devices, particularly in regions dependent on imports like asia-pacific and latin america. However, tariffs have also encouraged local manufacturing, regional sourcing, and strategic partnerships, supporting domestic production capabilities and reducing long-term dependency on cross-border supply chains.
The peripheral interventions market research report is one of a series of new reports that provides peripheral interventions market statistics, including peripheral interventions industry global market size, regional shares, competitors with a peripheral interventions market share, detailed peripheral interventions market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral interventions industry. This peripheral interventions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peripheral interventions are minimally invasive procedures designed to diagnose and treat conditions affecting the peripheral blood vessels outside the heart and brain, such as those in the legs, arms, or abdomen. These interventions commonly aim to restore circulation in the arteries of the limbs or abdomen using image-guided techniques.
The main products used in peripheral interventions include catheters, sheaths, stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, inferior vena cava (IVC) filters, and others. Catheters are thin, flexible tubes employed in medical procedures to deliver or remove fluids, administer medications, measure pressures, or guide other devices into blood vessels, organs, or body cavities for diagnostic or therapeutic purposes. The technologies involved include drug-eluting stents, balloon-expandable stents, self-expanding stents, rotational atherectomy, and directional atherectomy. These products are primarily applied in conditions such as peripheral artery disease, venous thromboembolism, and others, serving a diverse range of end users, including hospitals, ambulatory surgical centers, clinics, and research institutes.
The peripheral interventions market consists of revenues earned by entities providing services such as angioplasty and stenting procedures, atherectomy services, thrombectomy procedures, vascular imaging and diagnostics, and post-procedural patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Peripheral Interventions Market Characteristics
3. Peripheral Interventions Market Supply Chain Analysis
4. Global Peripheral Interventions Market Trends and Strategies
5. Peripheral Interventions Market Analysis of End Use Industries
7. Global Peripheral Interventions Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Peripheral Interventions Total Addressable Market (TAM) Analysis for the Market
9. Peripheral Interventions Market Segmentation
10. Peripheral Interventions Market Regional and Country Analysis
11. Asia-Pacific Peripheral Interventions Market
12. China Peripheral Interventions Market
13. India Peripheral Interventions Market
14. Japan Peripheral Interventions Market
15. Australia Peripheral Interventions Market
16. Indonesia Peripheral Interventions Market
17. South Korea Peripheral Interventions Market
18. Taiwan Peripheral Interventions Market
19. South East Asia Peripheral Interventions Market
20. Western Europe Peripheral Interventions Market
21. UK Peripheral Interventions Market
22. Germany Peripheral Interventions Market
23. France Peripheral Interventions Market
24. Italy Peripheral Interventions Market
25. Spain Peripheral Interventions Market
26. Eastern Europe Peripheral Interventions Market
27. Russia Peripheral Interventions Market
28. North America Peripheral Interventions Market
29. USA Peripheral Interventions Market
30. Canada Peripheral Interventions Market
31. South America Peripheral Interventions Market
32. Brazil Peripheral Interventions Market
33. Middle East Peripheral Interventions Market
34. Africa Peripheral Interventions Market
36. Peripheral Interventions Market Competitive Landscape and Company Profiles
37. Peripheral Interventions Market Other Major and Innovative Companies
40. Peripheral Interventions Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Peripheral Interventions Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses peripheral interventions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for peripheral interventions? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral interventions market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Catheters; Sheath; Stents; Guide Wires; Atherectomy Devices; Embolic Devices; Thrombectomy Devices; Inferior Vena Cava (IVC) Filters; Other Types2) By Technology: Drug-Eluting Stents; Balloon-Expandable Stents; Self-Expanding Stents; Rotational Atherectomy; Directional Atherectomy
3) By Application: Peripheral Artery Disease; Venous Thromboembolism; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Clinics; Specialty Vascular Centers
Subsegments:
1) By Catheters: Angiographic Catheters; Balloon Catheters; Guiding Catheters; Support Catheters2) By Sheath: Introducer Sheaths; Guiding Sheaths
3) By Stents: Bare Metal Stents; Drug-Eluting Stents; Covered Stents; Self-Expanding Stents; Balloon-Expandable Stents
4) By Guide Wires: Hydrophilic Guide Wires; Nitinol Guide Wires; Stainless Steel Guide Wires
5) By Atherectomy Devices: Directional Atherectomy Devices; Rotational Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices
6) By Embolic Devices: Embolization Coils; Embolic Protection Devices; Liquid Embolic Agents
7) By Thrombectomy Devices: Mechanical Thrombectomy Devices; Aspiration Thrombectomy Devices; Rheolytic Thrombectomy Devices
8) By Inferior Vena Cava (IVC) Filters: Permanent Filters; Retrievable Filters
9) By Other Types: Vascular Closure Devices; Hemostatic Agents; Guide Catheter
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Johnson & Johnson; Terumo Corporation; B. Braun Melsungen AG; Nipro Corporation; Teleflex Incorporated; Cook Group Incorporated; Merit Medical Systems Inc.; Lepu Medical Technology Beijing Co. Ltd.; Cordis Corporation; MicroPort Scientific Corporation; Penumbra Inc.; W. L. Gore & Associates Inc.; Reflow Medical Inc.; ArtVentive Medical Group Inc.; AngioDynamics Inc.; Cook Medical Inc.; BD Bard Peripheral Vascular Inc.; Endologix Inc.; Cardiovascular Systems Inc.; Surmodics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Peripheral Interventions market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Johnson & Johnson
- Terumo Corporation
- B. Braun Melsungen AG
- Nipro Corporation
- Teleflex Incorporated
- Cook Group Incorporated
- Merit Medical Systems Inc.
- Lepu Medical Technology Beijing Co. Ltd.
- Cordis Corporation
- MicroPort Scientific Corporation
- Penumbra Inc.
- W. L. Gore & Associates Inc.
- Reflow Medical Inc.
- ArtVentive Medical Group Inc.
- AngioDynamics Inc.
- Cook Medical Inc.
- BD Bard Peripheral Vascular Inc.
- Endologix Inc.
- Cardiovascular Systems Inc.
- Surmodics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.91 Billion |
| Forecasted Market Value ( USD | $ 15.28 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
